Product Code: 136959-0523
Home Infusion Therapy Market is Expected to Grow at 7.5% by 2031. Home infusion therapy refers to administration of biological and drugs in patient's home, wither by patient themselves, family, nurse and others. Home infusion services include patient training and education, administration, care coordination, pharmacy services and others. These services and supplies are usually provided by physicians and pharmacy staff, where initially, the patient picks up medications form physician's office. Nursing services for home care are also provided through agencies.
Geriatric population is the largest consumer of home infusion therapy. As the global population is ageing, this population possesses a high risk and susceptibility of this population group to develop chronic conditions that require infusion therapy. Growing demand for home healthcare by disabled patient group will additionally widen the base for home infusion therapy. Augmenting use of home infusion therapy also results in reduction in hospital readmission and in-patient stay, thus containing healthcare costs. Home infusion therapy is also instrumental in reducing the risk of contracting nosocomial infection thus presenting a potential market penetration opportunity.
Key players identified for the healthcare analytical testing market include but are not limited to:
- CVS/Coram
- Option Care Health
- CareFusion Corporation
- BriovaRx/Diplomat (UnitedHealth Optum)
- PharMerica
- Fresenius Kabi
- ICU Medical, Inc.
|
- B. Braun Melsungen AG
- Baxter
- BD
- Caesarea Medical Electronics
- Smiths Medical
- Terumo Corporation
- JMS Co. Ltd.
|
Historical & Forecast Period
This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Home Infusion Therapy market are as follows:
- Research and development budgets of manufacturers and government spending
- Revenues of key companies in the market segment
- Number of end users and consumption volume, price and value.
Geographical revenues generate by countries considered in the report:
Micro and macro environment factors that are currently influencing the Home Infusion Therapy market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
Segmentation
Product Type
- Infusion Pumps
- Elastomeric Pumps
- Electromechanical
- Gravity
- Others
- IV Sets
- IV Cannulas
- Needleless Connectors
Therapy Type
- Chemotherapy
- Enteral Nutrition
- Parenteral Nutrition
- Specialty Pharmaceuticals
- Others
Route of Administration
- Intramuscular
- Subcutaneously
- Epidural
Region Segment (2021-2031; US$ Million)
- North America
- U.S.
- Canada
- Rest of North America
- UK and European Union
- UK
- Germany
- Spain
- Italy
- France
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC
- Africa
- Rest of Middle East and Africa
Key questions answered in this report:
- What are the key micro and macro environmental factors that are impacting the growth of Home Infusion Therapy market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2031.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Home Infusion Therapy market?
- Which is the largest regional market for Home Infusion Therapy market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
- Which are the key trends driving Home Infusion Therapy market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Home Infusion Therapy market worldwide?
Table of Contents
1. Preface
- 1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted
2. Executive Summary
- 2.1. Market Snapshot: Global Home Infusion Therapy Market
- 2.2. Global Home Infusion Therapy Market, By Product Type, 2022 (US$ Million)
- 2.3. Global Home Infusion Therapy Market, By Therapy Type, 2022 (US$ Million)
- 2.4. Global Home Infusion Therapy Market, By Route of Administration, 2022 (US$ Million)
- 2.5. Global Home Infusion Therapy Market, By Geography, 2022 (US$ Million)
- 2.6. Attractive Investment Proposition by Geography, 2022
3. Home Infusion Therapy Market: Competitive Analysis
- 3.1. Market Positioning of Key Home Infusion Therapy Market Vendors
- 3.2. Strategies Adopted by Home Infusion Therapy Market Vendors
- 3.3. Key Industry Strategies
- 3.4. Tier Analysis 2022 Versus 2031
4. Home Infusion Therapy Market: Macro Analysis & Market Dynamics
- 4.1. Introduction
- 4.2. Global Home Infusion Therapy Market Value, 2021 - 2031, (US$ Million)
- 4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
- 4.4. Impact Analysis of Drivers and Restraints
- 4.5. See-Saw Analysis
5. Home Infusion Therapy Market: By Product Type, 2021-2031, USD (Million)
- 5.1. Market Overview
- 5.2. Growth & Revenue Analysis: 2022 Versus 2031
- 5.3. Market Segmentation
- 5.3.1. Infusion Pumps
- 5.3.1.1. Elastomeric Pumps
- 5.3.1.2. Electromechanical
- 5.3.1.3. Gravity
- 5.3.1.4. Others
- 5.3.2. IV Sets
- 5.3.3. IV Cannulas
- 5.3.4. Needleless Connectors
6. Home Infusion Therapy Market: By Therapy Type, 2021-2031, USD (Million)
- 6.1. Market Overview
- 6.2. Growth & Revenue Analysis: 2022 Versus 2031
- 6.3. Market Segmentation
- 6.3.1. Anti-infective
- 6.3.2. Endocrinology
- 6.3.2.1. Diabetes
- 6.3.2.2. Others
- 6.3.3. Hydration Therapy
- 6.3.3.1. Athletes
- 6.3.3.2. Others
- 6.3.4. Chemotherapy
- 6.3.5. Enteral Nutrition
- 6.3.6. Parenteral Nutrition
- 6.3.7. Specialty Pharmaceuticals
- 6.3.8. Others
7. Home Infusion Therapy Market: By Route of Administration, 2021-2031, USD (Million)
- 7.1. Market Overview
- 7.2. Growth & Revenue Analysis: 2022 Versus 2031
- 7.3. Market Segmentation
- 7.3.1. Intramuscular
- 7.3.2. Subcutaneously
- 7.3.3. Epidural
8. North America Home Infusion Therapy Market, 2021-2031, USD (Million)
- 8.1. Market Overview
- 8.2. Home Infusion Therapy Market: By Product Type, 2021-2031, USD (Million)
- 8.3. Home Infusion Therapy Market: By Therapy Type, 2021-2031, USD (Million)
- 8.4. Home Infusion Therapy Market: By Route of Administration, 2021-2031, USD (Million)
- 8.5.Home Infusion Therapy Market: By Region, 2021-2031, USD (Million)
- 8.5.1.North America
- 8.5.1.1. U.S.
- 8.5.1.1.1. Home Infusion Therapy Market: By Product Type, 2021-2031, USD (Million)
- 8.5.1.1.1. Home Infusion Therapy Market: By Therapy Type, 2021-2031, USD (Million)
- 8.5.1.1.1. Home Infusion Therapy Market: By Route of Administration, 2021-2031, USD (Million)
- 8.5.1.2. Canada
- 8.5.1.2.1. Home Infusion Therapy Market: By Product Type, 2021-2031, USD (Million)
- 8.5.1.2.1. Home Infusion Therapy Market: By Therapy Type, 2021-2031, USD (Million)
- 8.5.1.2.1. Home Infusion Therapy Market: By Route of Administration, 2021-2031, USD (Million)
- 8.5.1.3. Rest of North America
- 8.5.1.3.1. Home Infusion Therapy Market: By Product Type, 2021-2031, USD (Million)
- 8.5.1.3.1. Home Infusion Therapy Market: By Therapy Type, 2021-2031, USD (Million)
- 8.5.1.3.1. Home Infusion Therapy Market: By Route of Administration, 2021-2031, USD (Million)
9. UK and European Union Home Infusion Therapy Market, 2021-2031, USD (Million)
- 9.1. Market Overview
- 9.2. Home Infusion Therapy Market: By Product Type, 2021-2031, USD (Million)
- 9.3. Home Infusion Therapy Market: By Therapy Type, 2021-2031, USD (Million)
- 9.4. Home Infusion Therapy Market: By Route of Administration, 2021-2031, USD (Million)
- 9.5.Home Infusion Therapy Market: By Region, 2021-2031, USD (Million)
- 9.5.1.UK and European Union
- 9.5.1.1. UK
- 9.5.1.1.1. Home Infusion Therapy Market: By Product Type, 2021-2031, USD (Million)
- 9.5.1.1.1. Home Infusion Therapy Market: By Therapy Type, 2021-2031, USD (Million)
- 9.5.1.1.1. Home Infusion Therapy Market: By Route of Administration, 2021-2031, USD (Million)
- 9.5.1.2. Germany
- 9.5.1.2.1. Home Infusion Therapy Market: By Product Type, 2021-2031, USD (Million)
- 9.5.1.2.1. Home Infusion Therapy Market: By Therapy Type, 2021-2031, USD (Million)
- 9.5.1.2.1. Home Infusion Therapy Market: By Route of Administration, 2021-2031, USD (Million)
- 9.5.1.3. Spain
- 9.5.1.3.1. Home Infusion Therapy Market: By Product Type, 2021-2031, USD (Million)
- 9.5.1.3.1. Home Infusion Therapy Market: By Therapy Type, 2021-2031, USD (Million)
- 9.5.1.3.1. Home Infusion Therapy Market: By Route of Administration, 2021-2031, USD (Million)
- 9.5.1.4. Italy
- 9.5.1.4.1. Home Infusion Therapy Market: By Product Type, 2021-2031, USD (Million)
- 9.5.1.4.1. Home Infusion Therapy Market: By Therapy Type, 2021-2031, USD (Million)
- 9.5.1.4.1. Home Infusion Therapy Market: By Route of Administration, 2021-2031, USD (Million)
- 9.5.1.5. France
- 9.5.1.5.1. Home Infusion Therapy Market: By Product Type, 2021-2031, USD (Million)
- 9.5.1.5.1. Home Infusion Therapy Market: By Therapy Type, 2021-2031, USD (Million)
- 9.5.1.5.1. Home Infusion Therapy Market: By Route of Administration, 2021-2031, USD (Million)
- 9.5.1.6. Rest of Europe
- 9.5.1.6.1. Home Infusion Therapy Market: By Product Type, 2021-2031, USD (Million)
- 9.5.1.6.1. Home Infusion Therapy Market: By Therapy Type, 2021-2031, USD (Million)
- 9.5.1.6.1. Home Infusion Therapy Market: By Route of Administration, 2021-2031, USD (Million)
10. Asia Pacific Home Infusion Therapy Market, 2021-2031, USD (Million)
- 10.1. Market Overview
- 10.2. Home Infusion Therapy Market: By Product Type, 2021-2031, USD (Million)
- 10.3. Home Infusion Therapy Market: By Therapy Type, 2021-2031, USD (Million)
- 10.4. Home Infusion Therapy Market: By Route of Administration, 2021-2031, USD (Million)
- 10.5.Home Infusion Therapy Market: By Region, 2021-2031, USD (Million)
- 10.5.1.Asia Pacific
- 10.5.1.1. China
- 10.5.1.1.1. Home Infusion Therapy Market: By Product Type, 2021-2031, USD (Million)
- 10.5.1.1.1. Home Infusion Therapy Market: By Therapy Type, 2021-2031, USD (Million)
- 10.5.1.1.1. Home Infusion Therapy Market: By Route of Administration, 2021-2031, USD (Million)
- 10.5.1.2. Japan
- 10.5.1.2.1. Home Infusion Therapy Market: By Product Type, 2021-2031, USD (Million)
- 10.5.1.2.1. Home Infusion Therapy Market: By Therapy Type, 2021-2031, USD (Million)
- 10.5.1.2.1. Home Infusion Therapy Market: By Route of Administration, 2021-2031, USD (Million)
- 10.5.1.3. India
- 10.5.1.3.1. Home Infusion Therapy Market: By Product Type, 2021-2031, USD (Million)
- 10.5.1.3.1. Home Infusion Therapy Market: By Therapy Type, 2021-2031, USD (Million)
- 10.5.1.3.1. Home Infusion Therapy Market: By Route of Administration, 2021-2031, USD (Million)
- 10.5.1.4. Australia
- 10.5.1.4.1. Home Infusion Therapy Market: By Product Type, 2021-2031, USD (Million)
- 10.5.1.4.1. Home Infusion Therapy Market: By Therapy Type, 2021-2031, USD (Million)
- 10.5.1.4.1. Home Infusion Therapy Market: By Route of Administration, 2021-2031, USD (Million)
- 10.5.1.5. South Korea
- 10.5.1.5.1. Home Infusion Therapy Market: By Product Type, 2021-2031, USD (Million)
- 10.5.1.5.1. Home Infusion Therapy Market: By Therapy Type, 2021-2031, USD (Million)
- 10.5.1.5.1. Home Infusion Therapy Market: By Route of Administration, 2021-2031, USD (Million)
- 10.5.1.6. Rest of Asia Pacific
- 10.5.1.6.1. Home Infusion Therapy Market: By Product Type, 2021-2031, USD (Million)
- 10.5.1.6.1. Home Infusion Therapy Market: By Therapy Type, 2021-2031, USD (Million)
- 10.5.1.6.1. Home Infusion Therapy Market: By Route of Administration, 2021-2031, USD (Million)
11. Latin America Home Infusion Therapy Market, 2021-2031, USD (Million)
- 11.1. Market Overview
- 11.2. Home Infusion Therapy Market: By Product Type, 2021-2031, USD (Million)
- 11.3. Home Infusion Therapy Market: By Therapy Type, 2021-2031, USD (Million)
- 11.4. Home Infusion Therapy Market: By Route of Administration, 2021-2031, USD (Million)
- 11.5.Home Infusion Therapy Market: By Region, 2021-2031, USD (Million)
- 11.5.1.Latin America
- 11.5.1.1. Brazil
- 11.5.1.1.1. Home Infusion Therapy Market: By Product Type, 2021-2031, USD (Million)
- 11.5.1.1.1. Home Infusion Therapy Market: By Therapy Type, 2021-2031, USD (Million)
- 11.5.1.1.1. Home Infusion Therapy Market: By Route of Administration, 2021-2031, USD (Million)
- 11.5.1.2. Mexico
- 11.5.1.2.1. Home Infusion Therapy Market: By Product Type, 2021-2031, USD (Million)
- 11.5.1.2.1. Home Infusion Therapy Market: By Therapy Type, 2021-2031, USD (Million)
- 11.5.1.2.1. Home Infusion Therapy Market: By Route of Administration, 2021-2031, USD (Million)
- 11.5.1.3. Rest of Latin America
- 11.5.1.3.1. Home Infusion Therapy Market: By Product Type, 2021-2031, USD (Million)
- 11.5.1.3.1. Home Infusion Therapy Market: By Therapy Type, 2021-2031, USD (Million)
- 11.5.1.3.1. Home Infusion Therapy Market: By Route of Administration, 2021-2031, USD (Million)
12. Middle East and Africa Home Infusion Therapy Market, 2021-2031, USD (Million)
- 12.1. Market Overview
- 12.2. Home Infusion Therapy Market: By Product Type, 2021-2031, USD (Million)
- 12.3. Home Infusion Therapy Market: By Therapy Type, 2021-2031, USD (Million)
- 12.4. Home Infusion Therapy Market: By Route of Administration, 2021-2031, USD (Million)
- 12.5.Home Infusion Therapy Market: By Region, 2021-2031, USD (Million)
- 12.5.1.Middle East and Africa
- 12.5.1.1. GCC
- 12.5.1.1.1. Home Infusion Therapy Market: By Product Type, 2021-2031, USD (Million)
- 12.5.1.1.1. Home Infusion Therapy Market: By Therapy Type, 2021-2031, USD (Million)
- 12.5.1.1.1. Home Infusion Therapy Market: By Route of Administration, 2021-2031, USD (Million)
- 12.5.1.2. Africa
- 12.5.1.2.1. Home Infusion Therapy Market: By Product Type, 2021-2031, USD (Million)
- 12.5.1.2.1. Home Infusion Therapy Market: By Therapy Type, 2021-2031, USD (Million)
- 12.5.1.2.1. Home Infusion Therapy Market: By Route of Administration, 2021-2031, USD (Million)
- 12.5.1.3. Rest of Middle East and Africa
- 12.5.1.3.1. Home Infusion Therapy Market: By Product Type, 2021-2031, USD (Million)
- 12.5.1.3.1. Home Infusion Therapy Market: By Therapy Type, 2021-2031, USD (Million)
- 12.5.1.3.1. Home Infusion Therapy Market: By Route of Administration, 2021-2031, USD (Million)
13. Company Profile
- 13.1. CVS/Coram
- 13.1.1. Company Overview
- 13.1.2. Financial Performance
- 13.1.3. Product Portfolio
- 13.1.4. Strategic Initiatives
- 13.2. Option Care Health
- 13.2.1. Company Overview
- 13.2.2. Financial Performance
- 13.2.3. Product Portfolio
- 13.2.4. Strategic Initiatives
- 13.3. CareFusion Corporation
- 13.3.1. Company Overview
- 13.3.2. Financial Performance
- 13.3.3. Product Portfolio
- 13.3.4. Strategic Initiatives
- 13.4. BriovaRx/Diplomat (UnitedHealth Optum)
- 13.4.1. Company Overview
- 13.4.2. Financial Performance
- 13.4.3. Product Portfolio
- 13.4.4. Strategic Initiatives
- 13.5. PharMerica
- 13.5.1. Company Overview
- 13.5.2. Financial Performance
- 13.5.3. Product Portfolio
- 13.5.4. Strategic Initiatives
- 13.6. Fresenius Kabi
- 13.6.1. Company Overview
- 13.6.2. Financial Performance
- 13.6.3. Product Portfolio
- 13.6.4. Strategic Initiatives
- 13.7. ICU Medical, Inc.
- 13.7.1. Company Overview
- 13.7.2. Financial Performance
- 13.7.3. Product Portfolio
- 13.7.4. Strategic Initiatives
- 13.8. B. Braun Melsungen AG
- 13.8.1. Company Overview
- 13.8.2. Financial Performance
- 13.8.3. Product Portfolio
- 13.8.4. Strategic Initiatives
- 13.9. Baxter
- 13.9.1. Company Overview
- 13.9.2. Financial Performance
- 13.9.3. Product Portfolio
- 13.9.4. Strategic Initiatives
- 13.10. BD
- 13.10.1. Company Overview
- 13.10.2. Financial Performance
- 13.10.3. Product Portfolio
- 13.10.4. Strategic Initiatives
- 13.11. Caesarea Medical Electronics
- 13.11.1. Company Overview
- 13.11.2. Financial Performance
- 13.11.3. Product Portfolio
- 13.11.4. Strategic Initiatives
- 13.12. Smiths Medical
- 13.12.1. Company Overview
- 13.12.2. Financial Performance
- 13.12.3. Product Portfolio
- 13.12.4. Strategic Initiatives
- 13.13. Terumo Corporation
- 13.13.1. Company Overview
- 13.13.2. Financial Performance
- 13.13.3. Product Portfolio
- 13.13.4. Strategic Initiatives
- 13.14. JMS Co. Ltd.
- 13.14.1. Company Overview
- 13.14.2. Financial Performance
- 13.14.3. Product Portfolio
- 13.14.4. Strategic Initiatives